Synthetic ligands for PPAR&ggr; - review of patent literature 1994 - 1999

Author： Rami H.K.   Smith S.A.  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.5, 2000-05, pp. : 623-634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic ligands for peroxisome proliferator-activated receptor-α, review of the patent literature 2000 – 2003

By Miyachi Hiroyuki  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 607-618

Informa Healthcare

Access to resources Recommend Favorite

Oxytocin receptor ligands: a survey of the patent literature

By Gimpl Gerald  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 11, 2008-11 ,pp. : 1239-1251

Informa Healthcare

Access to resources Recommend Favorite

Estrogen receptor ligands: a patent review update

By Paterni Ilaria   Bertini Simone   Granchi Carlotta   Macchia Marco   Minutolo Filippo  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1247-1271

Informa Healthcare

Access to resources Recommend Favorite

Benzodiazepine receptor ligands: a patent review (2006 - 2012)

By Guerrini Gabriella   Ciciani Giovanna  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 843-866

Informa Healthcare

Access to resources Recommend Favorite

Novel M1 allosteric ligands: a patent review

By Kuduk Scott D   Beshore Douglas C  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1385-1398

Informa Healthcare

Access to resources Recommend Favorite